Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Development ; 142(17): 2981-95, 2015 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-26329601

RESUMEN

Yin Yang 1 (YY1) is a multifunctional zinc-finger-containing transcription factor that plays crucial roles in numerous biological processes by selectively activating or repressing transcription, depending upon promoter contextual differences and specific protein interactions. In mice, Yy1 null mutants die early in gestation whereas Yy1 hypomorphs die at birth from lung defects. We studied how the epithelial-specific inactivation of Yy1 impacts on lung development. The Yy1 mutation in lung epithelium resulted in neonatal death due to respiratory failure. It impaired tracheal cartilage formation, altered cell differentiation, abrogated lung branching and caused airway dilation similar to that seen in human congenital cystic lung diseases. The cystic lung phenotype in Yy1 mutants can be partly explained by the reduced expression of Shh, a transcriptional target of YY1, in lung endoderm, and the subsequent derepression of mesenchymal Fgf10 expression. Accordingly, SHH supplementation partially rescued the lung phenotype in vitro. Analysis of human lung tissues revealed decreased YY1 expression in children with pleuropulmonary blastoma (PPB), a rare pediatric lung tumor arising during fetal development and associated with DICER1 mutations. No evidence for a potential genetic interplay between murine Dicer and Yy1 genes during lung morphogenesis was observed. However, the cystic lung phenotype resulting from the epithelial inactivation of Dicer function mimics the Yy1 lung malformations with similar changes in Shh and Fgf10 expression. Together, our data demonstrate the crucial requirement for YY1 in lung morphogenesis and identify Yy1 mutant mice as a potential model for studying the genetic basis of PPB.


Asunto(s)
Epitelio/embriología , Epitelio/metabolismo , Pulmón/embriología , Pulmón/metabolismo , Morfogénesis , Factor de Transcripción YY1/metabolismo , Animales , Apoptosis , Tipificación del Cuerpo , Cartílago/anomalías , Cartílago/embriología , Cartílago/patología , Diferenciación Celular , Proliferación Celular , ARN Helicasas DEAD-box/metabolismo , Embrión de Mamíferos/anomalías , Embrión de Mamíferos/patología , Endodermo/embriología , Endodermo/metabolismo , Células Epiteliales/citología , Células Epiteliales/metabolismo , Factor 10 de Crecimiento de Fibroblastos/metabolismo , Proteínas Hedgehog/metabolismo , Humanos , Enfermedades Pulmonares/congénito , Enfermedades Pulmonares/patología , Ratones , Ratones Transgénicos , Modelos Biológicos , Miocitos del Músculo Liso/metabolismo , Miofibroblastos/patología , Fenotipo , Blastoma Pulmonar/metabolismo , Blastoma Pulmonar/patología , Ribonucleasa III/metabolismo , Tráquea/anomalías , Tráquea/embriología , Tráquea/patología
2.
An Acad Bras Cienc ; 85(1): 379-84, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23460425

RESUMEN

Vitamin C is essential for fish diets because many species cannot syntethize it. This vitamin is needed for bone and cartilage formation. Moreover, it acts as antioxidant and improve the immunological system. The present work investigated the effects of vitamin C diet supplementation to spotted sorubim (Pseudoplatystoma coruscans) fingerlings by frequency of bone and cartilage deformation. Ascorbyl poliphosphate (AP) was used as source of vitamin C in the diets for spotted sorubim fingerlings during three months. Six diets were formulated: one diet control (0 mg/kg of vitamin C) and 500, 1,000, 1,500, 2,000 and 2,500 mg AP/kg diets. Fishes fed without vitamin C supplementation presented bone deformation in head and jaws, and fin fragilities. Thus, 500 mg AP/kg diet was enough to prevent deformation and the lack of vitamin C supplementation worsening the development of fingerlings.


Asunto(s)
Deficiencia de Ácido Ascórbico/complicaciones , Ácido Ascórbico/administración & dosificación , Cartílago/anomalías , Enfermedades de los Peces/prevención & control , Perciformes/anomalías , Animales , Suplementos Dietéticos
3.
PLoS Genet ; 7(9): e1002294, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21966280

RESUMEN

Patients with neonatal severe hyperparathyroidism (NSHPT) are homozygous for the calcium-sensing receptor (CaR) mutation and have very high circulating PTH, abundant parathyroid hyperplasia, and severe life-threatening hypercalcemia. Mice with homozygous deletion of CaR mimic the syndrome of NSHPT. To determine effects of CaR deficiency on skeletal development and interactions between CaR and 1,25(OH)(2)D(3) or PTH on calcium and skeletal homeostasis, we compared the skeletal phenotypes of homozygous CaR-deficient (CaR(-/-)) mice to those of double homozygous CaR- and 1α(OH)ase-deficient [CaR(-/-)1α(OH)ase(-/-)] mice or those of double homozygous CaR- and PTH-deficient [CaR(-/-)PTH(-/-)] mice at 2 weeks of age. Compared to wild-type littermates, CaR(-/-) mice had hypercalcemia, hypophosphatemia, hyperparathyroidism, and severe skeletal growth retardation. Chondrocyte proliferation and PTHrP expression in growth plates were reduced significantly, whereas trabecular volume, osteoblast number, osteocalcin-positive areas, expression of the ALP, type I collagen, osteocalcin genes, and serum ALP levels were increased significantly. Deletion of 1α(OH)ase in CaR(-/-) mice resulted in a longer lifespan, normocalcemia, lower serum phosphorus, greater elevation in PTH, slight improvement in skeletal growth with increased chondrocyte proliferation and PTHrP expression, and further increases in indices of osteoblastic bone formation. Deletion of PTH in CaR(-/-) mice resulted in rescue of early lethality, normocalcemia, increased serum phosphorus, undetectable serum PTH, normalization in skeletal growth with normal chondrocyte proliferation and enhanced PTHrP expression, and dramatic decreases in indices of osteoblastic bone formation. Our results indicate that reductions in hypercalcemia play a critical role in preventing the early lethality of CaR(-/-) mice and that defects in endochondral bone formation in CaR(-/-) mice result from effects of the marked elevation in serum calcium concentration and the decreases in serum phosphorus concentration and skeletal PTHrP levels, whereas the increased osteoblastic bone formation results from direct effects of PTH.


Asunto(s)
Huesos/anomalías , Calcio/metabolismo , Cartílago/anomalías , Hiperparatiroidismo/genética , Osteoblastos/metabolismo , Hormona Paratiroidea/genética , Fósforo/metabolismo , Receptores Sensibles al Calcio/genética , Animales , Huesos/metabolismo , Calcio/sangre , Cartílago/metabolismo , Proliferación Celular , Condrocitos/metabolismo , Homocigoto , Hiperparatiroidismo/metabolismo , Ratones , Ratones Mutantes , Osteogénesis/genética , Hormona Paratiroidea/sangre , Fósforo/sangre , Receptores Sensibles al Calcio/deficiencia , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/metabolismo
4.
Hum Exp Toxicol ; 29(6): 439-50, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20237176

RESUMEN

Skeletal changes induced by treatment of pregnant rats with four potent teratogens, busulfan, acetazolamide, vitamin A palmitate, and ketoconazole, were evaluated using Alizarin Red S and Alcian Blue double-staining to investigate the relationship between drug-induced skeletal malformations and cartilaginous changes in the fetuses. Pregnant rats (N = 8/group) were treated once or twice between gestation days (GDs) 10 to 13 with busulfan at doses of 3, 10, or 30 mg/kg; acetazolamide at 200, 400, or 800 mg/kg; vitamin A palmitate at 100,000, 300,000, or 1,000,000 IU/kg; or ketoconazole at doses of 10, 30, or 100 mg/kg. Uterine evaluations and fetal external and skeletal examinations were conducted on GD 20. Marked skeletal abnormalities in ribs and hand/forelimb bones such as absent/ short/bent ribs, fused rib cartilage, absent/fused forepaw phalanx, and misshapen carpal bones were induced at the mid- and high-doses of busulfan and acetazolamide and at the high-dose of vitamin A palmitate and ketoconazole. Increased incidences of discontinuous rib cartilage (DRC) and fused carpal bone (FCB) were observed from the low- or mid-dose in the busulfan and acetazolamide groups, and incidences of FCB were increased from the mid-dose in the vitamin A palmitate and ketoconazole groups. Therefore, DRC and FCB were detected at lower doses than those at which ribs and hand/forelimb malformations were observed in the four potent teratogens.


Asunto(s)
Anomalías Inducidas por Medicamentos/patología , Huesos del Carpo/anomalías , Cartílago/anomalías , Costillas/anomalías , Teratógenos/toxicidad , Acetazolamida/administración & dosificación , Acetazolamida/toxicidad , Animales , Busulfano/administración & dosificación , Busulfano/toxicidad , Diterpenos , Relación Dosis-Respuesta a Droga , Femenino , Muerte Fetal/inducido químicamente , Desarrollo Fetal/efectos de los fármacos , Reabsorción del Feto/inducido químicamente , Peso Fetal/efectos de los fármacos , Feto/anomalías , Cetoconazol/administración & dosificación , Cetoconazol/toxicidad , Embarazo , Distribución Aleatoria , Ratas , Ésteres de Retinilo , Vitamina A/administración & dosificación , Vitamina A/análogos & derivados , Vitamina A/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA